Taylor v. Microgenics Corporation

CourtDistrict Court, S.D. New York
DecidedDecember 11, 2024
Docket7:21-cv-06452
StatusUnknown

This text of Taylor v. Microgenics Corporation (Taylor v. Microgenics Corporation) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Taylor v. Microgenics Corporation, (S.D.N.Y. 2024).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ----------------------------- --- -- + -- - GLADSTONE TAYLOR, : Plaintiff, : v. : : OPINION AND ORDER DAMON GLOVER, Community Correctional : Center Assistant, in his individual capacity; : 21 CV 6452 (VB) and EDUCATION SUPERVISOR RENEE : MULLIGAN, in her individual capacity, : Defendants. : ------------------------ -- -- - -- -- - $$ XX Briccetti, J.: Plaintiff Gladstone Taylor brings this Section 1983 action against defendants Community Correctional Center Assistant Damon Glover and Education Supervisor Renee Mulligan, employees at Fishkill Correctional Facility in Beacon, New York (“Fishkill”). Plaintiff claims defendants violated his constitutional rights under the Eighth and Fourteenth Amendments when they punished him for purportedly failing a drug test, resulting in, among other things, his removal from a work release program, loss of privileges, and loss of good time allowance. Now pending is defendants’ motion for summary judgment. (Doc. #134). For the reasons set forth below, the motion is GRANTED IN PART and DENIED IN PART. The Court has subject matter jurisdiction pursuant to 28 U.S.C. § 1331. BACKGROUND The parties have submitted memoranda of law, supporting declarations with exhibits, and statements of undisputed material facts pursuant to Local Civil Rule 56.1. Together, they reflect the following background. I. Plaintiff's Incarceration and Good Time Allowance Beginning in 2016, plaintiff was in the custody of the New York State Department of Corrections and Community Supervision (“DOCCS”). On November 13, 2019, a DOCCS Time

Allowance Committee (the “TAC”) recommended plaintiff be awarded eight months and twenty days good time credit, the maximum award for which plaintiff was statutorily eligible. As a result, his conditional release date was March 12, 2020. Plaintiff was incarcerated at Fishkill from June 2019 until his release in March 2020. While incarcerated at Fishkill, plaintiff participated in a temporary work release program, pursuant to which he spent two days a week at Fishkill and five days a week living with his family and working at a Wendy’s restaurant. As a participant in the program, plaintiff was entitled to special privileges at Fishkill, including a designated housing unit. Random drug testing was a condition of participating in the temporary work release program. Il. Drug Test and Misbehavior Report On January 9, 2020, after returning to Fishkill from work release, plaintiff underwent a random drug test by urinalysis and tested positive for opiates. As a result, he was barred from leaving the facility. On January 13, 2020, a DOCCS employee informed defendant Glover, who was responsible for overseeing participants in the temporary work release program, that plaintiff tested positive for opiates. Glover interviewed plaintiff regarding the test results. Plaintiff denied using opiates and insisted his test sample be sent to an outside laboratory for additional testing, but Glover informed him the sample had been thrown away. After the interview, Glover prepared a misbehavior report charging plaintiff with using drugs and violating temporary work release rules. The misbehavior report states plaintiff denied using any illegal drugs and instead told Glover he was “using Naproxen for pain and it has opiates in it.” (Doc. #136-2). However, the report states that medical staff at Fishkill advised Glover that Naproxen does not contain opiates.

Subsequently, a supervising lieutenant reviewed the misbehavior report and issued a Tier III disciplinary ticket against plaintiff. As a result, a Tier III disciplinary hearing on the misbehavior report was scheduled for January 27, 2020, and plaintiff's good time allowance award was automatically stayed. Ul. Tier II Disciplinary Hearing On January 29, 2020, after two one-day adjournments due to witness unavailability, defendant Mulligan conducted the Tier III disciplinary hearing. Plaintiff received prior notice of the hearing and had the opportunity to call and question witnesses. He requested three witnesses: Offender Rehabilitation Coordinator (“ORC”) Rubio, ORC Icarri, and Correction Officer Hernandez. (Doc. #136-3). Only ORC Rubio testified. Plaintiff pleaded not guilty to both charges in the misbehavior report. Although not reflected in the hearing transcript, plaintiff claims he tried to alert Mulligan that the “chain of procedure” with the urinalysis was not followed because his positive test sample was not tested a second time. (Doc. #136-1, Tr. at 157).! Moreover, plaintiff testified that Mulligan threatened him off-the-record at his disciplinary hearing, saying “if you plead not guilty, you’re not going to make it home” and that plaintiff “can’t beat the ticket.” (Id., Tr. at 138). Mulligan disputes both that these statements were made and that she communicated with plaintiff off-the-record. At the conclusion of the hearing, Mulligan found plaintiff guilty of both charges and imposed penalties of twenty-one days’ loss of programming and thirty days’ loss of commissary and package privileges. Plaintiff testified that Mulligan also revoked his visitation privileges and

Citations to “Tr. at __” refer to the page numbers at the bottom right of each transcript page.

placed him on cube confinement for a month, during which he was unable to move anywhere outside the area surrounding his bed and locker, use the bathroom, cook, or socialize without permission. Mulligan’s findings did not reference the alleged deficiencies with the urinalysis. On January 29, 2020, plaintiff appealed the disciplinary determination. IV. TRC Hearing and Removal from Temporary Work Release On February 6, 2024, plaintiff appeared before the Temporary Release Committee (the “TRC”) for a hearing on his continued participation in the temporary work release program. The TRC hearing was conducted by then-Senior ORC Patterson, ORC Gallo, and Glover. At the hearing, plaintiff denied using opiates and claimed his drug test was a false positive. Plaintiff also disputed that he had told Glover that Naproxen has opiates in it. Instead, plaintiff argued he told Glover he did not know if Naproxen contains opiates and that he had been told Naproxen is a narcotic. Glover denied inaccurately reporting plaintiff's statements and stated that medical staff informed him Naproxen actually decreases the excretion of opiates. The TRC recommended plaintiff be removed from the temporary work release program; Glover did not participate in the TRC’s vote or recommendation. On February 10, 2020, the designee of Fishkill’s Superintendent approved the TRC’s recommendation and removed plaintiff from the temporary work release program. V. TAC Reconsideration and Release On March 19, 2020, the TAC reconsidered plaintiff's eligibility for his good time allowance award in light of the Tier III disciplinary proceeding. The TAC recommended reinstating plaintiff's full award of eight months and twenty days good time allowance. On March 23, 2020, the superintendent endorsed this recommendation and on March 24, 2020, the commissioner approved the recommendation. (Doc. #136-7). Plaintiff became immediately eligible for conditional release and, on March 26, 2020, he was released from Fishkill.

VI. — Appeal of Disciplinary Determination On April 2, 2020, DOCCS granted plaintiffs appeal of his disciplinary determination and reversed and expunged the Tier III ticket, reasoning that the relevant DOCCS policy at the time required a second test to confirm plaintiffs test results. (Doc. #140 § 18). Plaintiff thereafter brought this action. DISCUSSION I.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wolff v. McDonnell
418 U.S. 539 (Supreme Court, 1974)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Sandin v. Conner
515 U.S. 472 (Supreme Court, 1995)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Dicks v. Chow
382 F. App'x 28 (Second Circuit, 2010)
Zalaski v. City of Bridgeport Police Department
613 F.3d 336 (Second Circuit, 2010)
Wilson v. Northwestern Mutual Insurance
625 F.3d 54 (Second Circuit, 2010)
Brown v. Eli Lilly and Co.
654 F.3d 347 (Second Circuit, 2011)
Hathaway v. Coughlin
99 F.3d 550 (Second Circuit, 1996)
Emmeth Sealey v. T.H. Giltner
197 F.3d 578 (Second Circuit, 1999)
Friedl v. City Of New York
210 F.3d 79 (Second Circuit, 2000)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
Taylor v. Microgenics Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/taylor-v-microgenics-corporation-nysd-2024.